Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it launched its Trumatch titanium 3D-printed implants designed for use in facial reconstructions in the US.

The company said it inked an exclusive distribution deal with 3D-printer and software solution supplier Materialise as part of the launch.

“DePuy Synthes offers advanced technologies for facial reconstruction, orthognathic surgery, distraction and cranial reconstruction. The addition of Titanium 3D-Printed Implants from Materialise will allow us to continue bringing these solutions to the marketplace, furthering our ability to advance patient care,” DePuy Synthes prez Juan-José Gonzalez said in a prepared statement.

DePuy Synthes said that with the launch, it is now able to offer Trumatch Orthognathics, which serves as a personalized total solution for corrective jaw surgery and includes virtual surgical planning and patient specific implants with a goal of improving accuracy, efficiency and outcomes.

The Trumatch titanium 3D-printed implants are based on CT scans of a patient’s skull and the outcomes of computer-aided surgical planning, the company said. DePuy Synthes asid it plans to begin marketing of the devices in mid-September.

“We have been using Trumatch Orthognathics for more than a year and the use of these personalized surgical guides and plates demonstrate a high predictability of maxillary positioning. In addition to saving time in the OR, the use of this new digital approach may achieve surgeon independent accuracy of maxillary positioning, facilitating resident training even in the treatment of complex malformations,” Dr. Alexander Schramm of Germany’s University Hospital and Military Hospital Ulm said in a press release.

Last month, DePuy Synthes said it inked an exclusive agreement with Medical Enterprises Distribution to co-market its ME1000 surgical impactor, designed for use in total hip arthroplasty procedures.